The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer's Disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.